Hong Kong Pharma Stock News

WuXi Biologics (Cayman) (SEHK:2269) announced new alliances with Vertex Pharmaceuticals and Sinorda Biomedicine for co-development and manufacturing of biologics targeting autoimmune diseases. The company also expanded its agreement with HanchorBio to cover next generation fusion protein programs. Together, these collaborations broaden WuXi Biologics' role as a global contract research, development and manufacturing partner across multiple therapeutic modalities. WuXi Biologics focuses on...

BYD (SEHK:1211) is back in focus after reporting a 30% year on year drop in January sales to about 210,000 vehicles, its fifth straight monthly decline, which coincided with weaker government incentives. See our latest analysis for BYD. The weak January sales and reduced incentives have come after a tough spell for the shares, with a 7 day share price return of 10.36% and a 1 month share price return of 8.01%, leaving the share price at HK$91.25. Even so, the 1 year total shareholder return...

In recent days, Ford Motor confirmed it is in talks with Zhejiang Geely Holding Group about using Ford’s excess plant capacity in Valencia, Spain, potentially including platform and technology sharing for European vehicle production. This prospective collaboration could allow Geely to assemble cars within the European Union, helping reduce tariff exposure while giving Ford a way to improve utilisation of its underused facilities. Next, we examine how this potential Ford manufacturing tie-up,...

Nexteer Automotive Group Limited's ( HKG:1316 ) price-to-earnings (or "P/E") ratio of 19.3x might make it look like a...

China Medical System Holdings (SEHK:867) has secured approval from China's National Medical Products Administration to start clinical trials for CMS-D017, an oral complement factor B inhibitor targeting paroxysmal nocturnal hemoglobinuria. See our latest analysis for China Medical System Holdings. Trading at HK$14.58, China Medical System Holdings has seen firm momentum recently, with a 7 day share price return of 4.59%, a 30 day share price return of 7.44%, and a 1 year total shareholder...

Smart Kreate Group Limited (SKG) recently announced a collaboration between its newly formed logistics technology group and KEC (Hong Kong) Limited, a subsidiary of KLN Logistics Group, to co-develop AI-powered, cloud-based logistics SaaS platforms for enterprise and SME customers worldwide. This partnership gives KLN Logistics Group access to SKG’s logistics technology and AI optimization capabilities while contributing its own global infrastructure, positioning both parties within the...

Shenzhen Dobot Corp Ltd ( HKG:2432 ) is possibly approaching a major achievement in its business, so we would like to...

Insiders who bought CN¥529.5m worth of Easou Technology Holdings Limited's ( HKG:2550 ) stock at an average buy price...

When close to half the companies in Hong Kong have price-to-earnings ratios (or "P/E's") below 12x, you may consider...

We note that a Shanghai Gench Education Group Limited ( HKG:1525 ) insider, Xiangzhan Zheng, recently sold HK$406k...

To the annoyance of some shareholders, Bojun Education Company Limited ( HKG:1758 ) shares are down a considerable 29...

China Energy Development Holdings Limited ( HKG:228 ) shares have continued their recent momentum with a 29% gain in...

The simplest way to invest in stocks is to buy exchange traded funds. But if you pick the right individual stocks, you...

To the annoyance of some shareholders, Universe Entertainment and Culture Group Company Limited ( HKG:1046 ) shares are...

Asia Tele-Net and Technology Corporation Limited ( HKG:679 ) shareholders have had their patience rewarded with a 52...

As global markets navigate a complex landscape, Asian economies remain a focal point for investors seeking growth opportunities. Amidst this backdrop, penny stocks—often smaller or newer companies with potential for significant returns—continue to capture interest. Despite being considered niche investments, these stocks can reveal hidden value when supported by strong financial health and clear growth trajectories.

With a price-to-earnings (or "P/E") ratio of 16.6x CLP Holdings Limited ( HKG:2 ) may be sending bearish signals at the...

Recently, Zhejiang Leapmotor Technology released further details on its domestic share subscription under a general mandate, confirming state-owned Jinyi High-Tech as the subscribing party. The company explicitly clarified that Jinyi High-Tech and its ultimate owner are independent third parties, which may ease investor concerns around governance and compliance with Hong Kong listing rules. We will now examine how this clarification of Jinyi High-Tech as an independent subscriber influences...

CITIC Telecom International Holdings announced that Chief Financial Officer and Executive Director Mr. Luan Zhenjun resigned from both roles on January 30, 2026, citing other work arrangements and prompting a search for his replacement. This simultaneous departure from the finance leadership and the board raises questions about continuity in financial oversight and decision-making at the company. We will now examine how the resignation of the long-serving Chief Financial Officer shapes CITIC...

Why MMG’s latest guidance matters for shareholders MMG (SEHK:1208) has issued fresh guidance on its 2025 earnings and production plans, giving you clearer visibility on expected profitability and output across its core copper and zinc operations. The company is guiding for unaudited 2025 net profit after tax attributable to equity holders of US$500 million to US$520 million, alongside detailed volume targets at Las Bambas, Kinsevere, Khoemacau, Dugald River and Rosebery. See our latest...

If you are wondering whether Tencent Holdings is still priced attractively after recent swings, it helps to step back and look at what the current share price might be implying about its long term value. The stock most recently closed at HK$558.0, with a 7 day return of a 10.1% decline and a 30 day return of a 10.6% decline. The return over the last year sits at 34.7% and the 3 year return at 49.6%, while the 5 year return is a 17.9% decline. Recent market attention has focused on Tencent's...

In January 2026, MicroPort Scientific Corporation issued consolidated earnings guidance indicating a turnaround to profitability for 2025, forecasting a net profit of at least US$20 million versus an audited net loss of about US$268 million in 2024. This expected swing of very large magnitude in bottom-line performance highlights a significant shift in the company’s operational and financial trajectory. Next, we will examine how this anticipated return to profitability could influence...

Ascletis Pharma recently filed a follow-on equity offering of HK$843.54 million via a subsequent direct listing, issuing 69,256,000 ordinary shares at HK$12.18 each. The fundraising follows positive Phase III data for denifanstat in moderate-to-severe acne and progress with ASC30 in metabolic disease, underscoring Ascletis’s late-stage pipeline momentum. We’ll now explore how this combination of positive Phase III acne data and a sizable equity raise shapes Ascletis Pharma’s investment...

In January 2026, Chinese automaker BYD reported a 30% year-on-year drop in global vehicle sales to 210,051 units, its fifth consecutive monthly decline amid reduced government incentives for electric vehicles at home and abroad. This setback comes after BYD transformed itself over two decades from a battery specialist into China’s largest automaker, with very large increases in annual vehicle sales, revenue and net income between 2020 and 2024. We’ll now examine how this abrupt sales decline...